Cramer Remix: This industry isn't dead yet!

When Jim Cramer was a hedge fund manager, he was looking to spend. Give him a thesis, any thesis, and he was a buyer!

This is exactly the mind frame demonstrated by money managers who are desperate to put cash to work and scrounge up new ideas and reasons to make a good buy. Many may think that an industry like retail is dead, with reports of slow mall traffic hitting the numbers hard. But Cramer still sees opportunity for a buyer.

They are finding them in spades, too, with the market rallying yet again on Monday.

Cramer knows that with the year ending quickly, we are dealing with a limited window of time to jump in and get some performance. All of the opportunity with cheap prices right now are a perfect recipe for prices to go higher in 2015.

So, to make it easier for the money managers to jump into this window of opportunity, he went sector by sector to highlight the buying opportunities that just waiting to be worked right now.

Read MoreCramer's recipe for high prices in 2015

Daniel Loeb
Simon Dawson | Bloomberg | Getty Images
Daniel Loeb

With so much opportunity in the market, clearly CEOs of companies are reaping the benefits.

Where do we draw the line between feeling bad for a CEO and knowing that they are paid well for what they do?

That is what was going through Cramer's mind when he saw the peace treaty announced between Dow Chemical's Andrew Liveris and Dan Loeb of Third Point on Friday.

Third Point reportedly owns 2 percent of Dow's shares and struck a treaty with Dow that allowed Third Point to appoint two men as directors on Dow's board. Third Point selected Steve Miller, the chairman of AIG, and Ray Milchovich, former CEO of Foster Wheeler and now lead director at Nucor.

Loeb released a three-minute video with a stentorian announcer talking about bad decisions and broken promises that the company has made.

"Loeb's video was vicious, to say the least, and I say that as someone who regularly berates underperforming CEOs on the 'Mad Money' wall of shame," Cramer added.

Read MoreCramer: Check your tactics at the door, Dan Loeb

For the past month, companies like Michael Kors and Urban Outfitters have claimed that the declining mall traffic has led them to report disappointing numbers.

If that is the case, then why do people keep going to mall-based stores like Victoria's Secret and Bath & Body Works, two large chains owned by L Brands? They reported terrific numbers last Wednesday and didn't cry about slow mall traffic.

"There are two ways to explain this. Either people really have stopped going to the mall, and L Brands managed to triumph over these mall blues. Or the whole 'nobody goes to the mall anymore' alibi needs to be taken less seriously and L Brands is simply out-executing the other shopping-mall focused retailers," the "Mad Money" host said.

Cramer thinks it is a little of both. That is why he recommends that L Brands is worth owning. Even though the company has enjoyed a monster rally in the past few months and could be on the edge of peaking, Cramer thinks there could be some room to run here. That's because L Brands' traffic was up, even as overall mall traffic levels have been depressed.

Read More Cramer speculates - is the mall really dead?

Yahoo President and CEO Marissa Mayer delivers a keynote address at the 2014 International CES in Las Vegas.
Getty Images
Yahoo President and CEO Marissa Mayer delivers a keynote address at the 2014 International CES in Las Vegas.

Another stock that could have a lot more life in it, is Regeneron. This is a $410 biotech stock that has rallied 49 percent year-to-date.

"For those of you who are sitting on the sidelines telling yourself that Regeneron has run up way too much, that you missed it and it's just insanely risky to buy something after such an epic move, I'm telling you that the upside here is far from over," Cramer said.

The "Mad Money" host initially recommended this stock as one of the four horsemen of the big pharma apocalypse in his book "Get Rich Carefully," and he thinks it is not too late to pull the trigger on this one.

The company has three blockbusters in its pipeline that could signal growth. The first is Dupilumab, a treatment for atopic dermatitis; second is Alirocumab, an anti-cholesterol drug; and the third is Sarilumab, for rheumatoid arthritis.

If they receive FDA approval, then they could provide peak sales potential of more than $11 billion. So while this stock is not exactly cheap, it certainly isn't a one-trick pony.

"I think it's worth putting on a small position right now just in case we don't get any weakness," Cramer recommended.

One thing that really gets Cramer's goat is when CEOs create a false opportunity through buybacks. And he's not talking about your local bartender giving you a free beer.

Cramer is wholeheartedly in agreement that it is a great idea to grow a business by putting more money into it, if your business needs the cash to grow.

But it seems like these days that most companies are creating a buyback or dividend because they don't have any other opportunities available for shareholders. So rather than create value internally, they look to create value by announcing a buyback. Is that such a bad thing though?

Yahoo, for example, has made many good investments under the guidance of Marissa Mayer. She did it by strategic acquisitions and focusing on growth the business. Apple is also another great success story.

"If there were some powerful, winning initiatives that could really move the needle, I am quite confident that Apple would seize them," Cramer added.

Opportunities were also pointed out in the Lightning Round, when Cramer fired off his take on a few callers' favorite stocks:

Cliffs Natural Resources: "My charitable trust owns Valet, and it's been one of the worst disasters we have ever had. You always have to own the good ones and the bad ones, and this one has been a terrible one. I do not want you in Cliff."

IMS Health Holdings: "It's okay. I prefer Quintiles if you want to get into that kind of service business, and I even prefer McKesson. I think both are better."

Read MoreLightning Round: Do not own this